🔗 Share this article

Texas Attorney General Paxton is filing a lawsuit against the makers of acetaminophen, alleging the companies withheld potential risks that the pain reliever created to pediatric brain development.

This legal action arrives four weeks after Former President Trump publicized an unsubstantiated connection between consuming Tylenol - also known as paracetamol - during pregnancy and autism in young ones.

Paxton is suing Johnson & Johnson, which once produced the drug, the exclusive pain medication suggested for expectant mothers, and the current manufacturer, which now manufacturers it.

In a official comment, he said they "betrayed America by making money from pain and marketing drugs ignoring the potential hazards."

The manufacturer asserts there is lacking scientific proof connecting acetaminophen to autism spectrum disorder.

"These companies lied for decades, intentionally threatening countless individuals to boost earnings," the attorney general, a Republican, declared.

The company stated officially that it was "deeply concerned by the spread of false claims on the reliability of acetaminophen and the possible consequences that could have on the well-being of American women and children."

On its website, Kenvue also said it had "continuously evaluated the pertinent research and there is no credible data that shows a verified association between using acetaminophen and autism."

Organizations speaking for doctors and medical practitioners share this view.

ACOG has stated paracetamol - the primary component in Tylenol - is a restricted selection for women during pregnancy to treat discomfort and fever, which can pose major wellness concerns if left untreated.

"In over twenty years of investigation on the use of paracetamol in pregnancy, zero credible investigations has definitively established that the use of paracetamol in any trimester of pregnancy results in brain development issues in young ones," the organization commented.

The court filing mentions latest statements from the former administration in asserting the medication is allegedly unsafe.

In recent weeks, Trump caused concern from public health officials when he instructed women during pregnancy to "resist strongly" not to use Tylenol when unwell.

The FDA then issued a notice that medical professionals should consider limiting the usage of acetaminophen, while also mentioning that "a proven link" between the drug and autism spectrum disorder in minors has remains unverified.

Health Secretary RFK Jr, who supervises the FDA, had promised in April to initiate "extensive scientific investigation" that would establish the cause of autism in a matter of months.

But authorities warned that identifying a single cause of autism - thought by researchers to be the result of a complicated interplay of inherited and surrounding conditions - would prove challenging.

Autism is a category of permanent neurological difference and impairment that affects how individuals encounter and engage with the surroundings, and is recognized using physician assessments.

In his legal document, the attorney general - who supports Trump who is campaigning for federal office - asserts the manufacturer and Johnson & Johnson "deliberately disregarded and sought to suppress the evidence" around acetaminophen and autism.

The lawsuit seeks to make the corporations "destroy any marketing or advertising" that asserts Tylenol is reliable for pregnant women.

The court case echoes the grievances of a collection of parents of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who sued the manufacturers of acetaminophen in 2022.

A federal judge dismissed the legal action, saying investigations from the parents' expert witnesses was inconclusive.